Psychopharmacology and Psychiatry Updates

Faculty: Robert Hudak, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here
Earn 1.25 CME: Treatment-Resistant OCD: From SSRIs to Augmentation
Second-Generation Antipsychotics for OCD Augmentation: Third-Line Agents

In this episode, we review a JAMA Psychiatry study of over 4 million pregnancies examining first-trimester Z-drug exposure and congenital malformations. Dr. Amanda Koire explains why overall risk wasn't increased, what the neural tube defect signal means, and how to evaluate insomnia before prescribing.
Faculty: Amanda Koire, M.D., Ph.D.
Host: Flavio Guzmán, M.D.
Learn more about our membership here
Earn 0.75 CMEs: Quick Take Vol. 86
Are Z-Drugs Safe in the First Trimester of Pregnancy?

Faculty: Robert Hudak, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here
Earn 1.25 CME: Treatment-Resistant OCD: From SSRIs to Augmentation
Glutamatergic Augmentation in OCD: Memantine, Riluzole, Lamotrigine and Other Agents

Faculty: Oliver Freudenreich, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here
Earn 0.75 CMEs: Quick Take Vol. 85
Schizophrenia: Which of Seven Antipsychotics Wins on Acute Efficacy and Safety?

Faculty: Robert Hudak, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here
Earn 1.25 CME: SSRI Dosing for OCD: Beyond FDA Guidelines
Treatment-Resistant OCD: From SSRIs to Augmentation